Status:
COMPLETED
Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
OCHIN, Inc.
Conditions:
Diabetes Mellitus
Cardiovascular Diseases
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of the ALL Study is to determine the effectiveness of the dissemination of the ALL intervention from an integrated care setting into Community Health Centers (CHCs) by measuring changes in...
Detailed Description
The ALL Initiative ('ALL') is a population-level management program developed at Kaiser Permanente (KP). It seeks to decrease cardiovascular disease (CVD) morbidity and mortality in patients with diab...
Eligibility Criteria
Inclusion
- Convenience sample of 11 community health clinics (CHCs) that are members of OCHIN, Inc.
Exclusion
- none, for study CHCs
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
4856 Patients enrolled
Trial Details
Trial ID
NCT02299791
Start Date
September 1 2010
End Date
May 1 2014
Last Update
October 4 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.